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Introduction
Cyclooxygenases, lipoxygenases and cytochromes P450 (CYP gene products) activate arachidonic acid. Prostanoids, hydroxy and epoxy fatty acids generated by these enzyme systems mediate signals involved in epidermal homeostasis, skin diseases and cancers. These lipid mediators are implicated in mechanisms regulating diverse cellular processes including epidermal cell proliferation and differentiation, cutaneous responses to inflammation and environmental cell damage and cutaneous immune responses (recently reviewed by Ikai, 1999; Iversen and Kragballe, 2000; Marks et al., 2000; Ziboh et al., 2000; Kabashima and Miyachi, 2004) .
In mouse skin, epidermal cyclooxygenases generate mainly prostaglandins E 2 and D 2 from arachidonate. 12-Hydroxyeicosatetraenoic acid (12-HETE) is the main hydroxy fatty acid generated (Hammarström et al., 1979; Bedford et al., 1983; Ruzicka et al., 1983) , and levels of these enzyme activities are regulated as a function of the differentiation state of the epidermal cells (Henke et al., 1986; Cameron et al., 1990) .
In human skin, epidermal cyclooxygenases generate mainly prostaglandins E 2 and F 2α from arachidonate. The main hydroxy fatty acids generated are 12-and 15-hydroxyeicosatetraenoic acids (12-/15-HETE), and the ratio of these regioisomers is influenced by the differentiation state of epidermal cells (reviewed: Iversen and Kragballe, 2000; Ziboh et al., 2000) .
The cytochrome P450 superfamily includes 57 putatively functional CYP genes in humans (Nelson et al., 2004) . CYP enzymes have critical roles in metabolism of diverse natural and foreign compounds (Nebert and Russell, 2002) . Several are active Arachidonic acid monooxygenases typically generate multiple products in a regio-and stereo-specific manner (Capdevila and Falck, 2002) . In addition to epoxy-and ω/ω-1 hydroxy fatty acids, they can catalyze bis-allylic oxidations such that in a given tissue 12-and 15-HETE regioisomers, for example, potentially arise from both lipoxygenase and CYP-dependent metabolism.
The biosynthesis and functions of CYP-derived eicosanoids in the skin are poorly understood even though this enzyme system likely generates a large number of biologically active lipid mediators in epidermal cells. Cytochromes P450 require electron transfer proteins to transfer electrons from NADPH to the enzyme active site.
Hence, CYP-derived products are generally not observed under assay conditions used to study cyclooxygenase and lipoxygenase mediated metabolism. The first evidence that epidermal cells generate CYP-derived epoxyeicosatrienoic (EET) acids was obtained using human keratinocyte cell suspensions, in which cell membranes and reducing environment remained intact (Holtzman et al., 1989) . Although analyte identity was not proven in these studies, mass spectrometry was used in a subsequent study to measure cellular levels of EETs arising from endogenous arachidonic acid, in both human and mouse epidermal cells (Ladd et al., 2003; Du et al., 2005) . These results confirmed that catalytically active epoxygenases are expressed in epidermal cells since CYP enzymes are the only known catalytic source of EETs.
Previously we identified CYP2B19 as a major source of EET formation in mouse skin (Du et al., 2005) . In the present study, we aimed to demonstrate that mouse epidermal microsomes generate EETs when reconstituted in the presence of [1- arachidonate. To further establish roles for CYP2B19, we aimed to compare the regioand stereo-specificity of EETs formed by mouse epidermal microsomes with those generated by E. coli-expressed CYP2B19 (Keeney et al., 1998) . Instead of CYPderived EETs, we identified intermediates in a biosynthetic pathway not previously described in mouse skin that leads to formation of 8, .
This article has not been copyedited and formatted. The final version may differ from this version. peeled from the dermis after a 3-h incubation at 4ºC in 0.3% Dispase II (Sigma-Aldrich, St. Louis, MO), in phosphate buffered saline. Tissues were disrupted by three 1-min pluses at maximum speed (≈26,000 rpm), using a Polytron PT3100 fitted with a 12-mm generator with knives (PT-DA3013/2TM; Brinkmann Instrument Inc., Westbury, NY).
Samples were chilled for one minute between pulses. Homogenates were centrifuged for 20 min at 900 x g and 4ºC. The 900 x g supernatants were centrifuged for 30 min at 12,000 x g and 4°C. The 12,000 x g supernatants were centrifuged for 60 min at 100,000 x g and 4°C. If not used immediately, the 100,000 x g microsomal pellets were overlaid with 1-ml of 30% glycerol in 0.05 M Tris-HCl pH 7.4 and frozen at -30°C for up to two months. Before use, the glycerol overlay was removed, and pellets were washed 
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(Sigma-Aldrich, St. Louis, MO), as described .
Dihydroxyeicosatrienoic acids (DiHETrE) were prepared from EETs as described (Zeldin et al., 1993) , by hydrolysis in 50% CH 3 COOH in water for 12-h at 45°C under argon, with constant mixing. Synthesized EETs and DiHETrEs were purified before use by reversed-phase HPLC. minute at 35% B, followed by a linear gradient program from 35% B to 100% B over 14 minutes, then held at 100% B for 7 minutes. LC/MS experiments were done using negative electrospray ionization (ESI) using the standard DecaXP ESI source; nitrogen was used for both the sheath and auxiliary drying gases. The ESI spray potential was held at 3.5-kV, and the heated capillary ion transfer tube was held at 300ºC. An ion source declustering potential of 10-eV was employed to enhance signal intensity.
Liquid chromatography mass spectrometry (LC/MS
Optimal ESI operating conditions were established using a post-column infusion of arachidonic acid. Full scan spectra were recorded over the mass range m/z 200-400, products were observed when microsomes were preheated at 65ºC for 10-min, indicating the two NADPH-dependent products arise enzymatically (data not shown).
We detected product co-eluting with a single EET regioisomer (14,15-EET), even though epoxygenases including CYP2B19 typically generate two or more EET regioisomers. This could not be explained by epoxide hydrolase-dependent hydrolysis of EET regioisomers to the corresponding vicinal diols. The soluble epoxide hydrolase inhibitor N-adamantanyl-N'-dodecanoic acid urea (10-100 µM) had no discernable effect on the profile of eicosanoids generated from arachidonate by mouse epidermal microsomes (data not shown). Minor products having similar retention times as authentic DiHETrEs were formed regardless of whether NADPH was added (Fig. 1 ).
There was also no evidence for 5,6-DiHETrE 1,5-lactone, which could be resolved from product I in the reversed-phase HPLC system. We concluded that DiHETrEs were not generated at detectable levels.
This article has not been copyedited and formatted. The final version may differ from this version. Accumulation of the NADPH-dependent product I increased linearly only over 10 min, at protein concentrations up to 1 mg/ml for epidermal microsomes or 4 mg/ml for whole skin microsomes. We reasoned that NADPH-dependents products would be more easily detected if we could eliminate the competition for substrate by epidermal lipoxygenases and cyclooxygenases. However, we were unable to selectively inhibit these NADPH-independent activities towards arachidonate (inhibitor data not shown).
At all concentrations tested, the lipoxygenase inhibitors nordihydroguaiaretic acid (2-50 µM) and baicalein (0.1-5 µM) inhibited at least partially the formation of product I. This effect could be nonspecific or it could indicate lipoxygenase activities were involved in product I formation. Because the cycIooxygenase inhibitor indomethacin (25-50 µM)
increased product I formation modestly (range: 30%-300%), we routinely preincubated microsomes with 25-µM indomethacin, even though this drug had no measurable effect on NADPH-independent product formation. Inexplicably, the partial inhibition of product I due to nordihydroguaiaretic acid or baicalein was reversed by preincubating microsomes with both indomethacin and lipoxygenase inhibitor.
To prove whether product I was the CYP2B19 product 14,15-EET, a mixture of These entities proved to be chemically distinct ( Fig. 2A) , a result confirmed by the apparent stability of product I in the presence of acetic acid (Fig. 2B) (Fig. 2C ). Previously we used mass spectrometry to prove that CYP2B19 protein is expressed and that cellular EET accumulates in mouse epidermal keratinocytes (Du et al., 2005 ). Yet, under the assay conditions epidermal microsomes did not form Mouse epidermal microsomes generate 12-HETrE from arachidonic acid.
Spectral data indicated the NADPH-dependent products (I and II) were not conjugated dienes, dienones or trienes since neither had demonstrable absorbance at 237-or 280-nm (Table I) . Hydroxyeicosatrienoic acid regioisomers were evaluated since these eicosanoids have similar spectral properties as the epidermal products I and II. Neither of the NADPH-dependent products co-eluted with 15-hydroxy-8,11,13-eicosatrienoic acid (15-HETrE), resolved by reversed-phase HPLC. Product II coeluted with 12-HETrE (Table 1) , an eicosanoid formed from arachidonate by bovine corneal and rat epidermal microsomes (Murphy et al., 1988; Nishimura et al., 1991; Van Wauwe et al., 1991) .
To prove whether the intermediates involved in 12-HETrE synthesis were also present in the in vitro reactions, we purified products I, II, III and IV (from Fig. 1 ).
Each of these products was mixed individually with a selected reference compound, and the mixtures were resolved on two chromatographic systems. The NADPH-dependent product II was identified as 12-HETrE since it co-eluted with this reference compound on reversed-phase and normal phase HPLC systems (Table 1) . Product IV, a major 15 NADPH-independent product, was assumed to be HETE because it had an absorbance maximum at 237-nm, indicative of a conjugated diene chromophore. Product IV coeluted with 12-HETE in both chromatographic systems (Table 1) . The minor NADPHindependent product III had an absorbance maximum at 282-nm in our reversedphase solvent system, indicative of a conjugated dienone chromophore. Product III co-eluted with 12-oxo-ETE in both chromatographic systems (Table 1) . Finally, the NADPH-dependent product I, previously shown not to be an epoxy fatty acid, co-eluted with 12-oxo-ETrE in both chromatographic systems (Table 1) . We concluded from these chromatographic and spectral data that mouse epidermal microsomes contain competent enzymes that generate all of the intermediates in the 12-HETrE biosynthetic pathway (Fig. 3) .
Mass spectral analyses confirm that mouse epidermal microsomes
generate 12-oxo-ETrE and 12-HETrE from arachidonic acid. We confirmed the structures of the two NADPH-dependent products 12-oxo-ETrE (I) and 12-HETrE (II), using LC/ESI/MS (Fig. 4) . The LC elution time and ESI tandem mass spectrum of product II were identical to those obtained for authentic 12-HETrE ( Fig. 4A-D may result from internal cleavages as indicated (Fig. 4H) .
As a positive control, we also analyzed product IV, identified as 12-HETE (Table   1 ). The LC elution time and ESI tandem mass spectrum of product IV were identical to those for authentic 12-HETE (data not shown). We did not subject product III/12-oxo- Two end products formed from arachidonate--12-HETE and lesser amounts of 12-HETrE (Fig. 5) . To ascertain whether CYP proteins were involved in their synthesis, we used 1-aminobenzotriazole, a mechanism-based inhibitor of cytochrome P450
having low isoform selectivity. Pretreatment of mouse epidermal microsomes with 100- 
Discussion
Regioisomeric EETs generated from endogenous arachidonic acid are present in mouse epidermal tissue and differentiating epidermal cell cultures, indicating the presence of catalytically active epoxygenases (Keeney et al., 1998; Du et al., 2005) . As existing evidence suggests mouse CYP2B19 is mainly responsible for cellular EET formation in mouse skin (Du et al., 2005) , we set out to demonstrate that this keratinocyte-specific epoxygenase in epidermal microsomes is responsible for generating EETs from [1-
Instead of EET formation, we identified a NADPH-dependent pathway leading to biosynthesis of 12-HETrE. This is the first report showing this pathway is active in mouse skin.
A novel feature of mouse epidermal microsomes is that we were able to identify and characterize all four intermediates in synthesis of 12-HETrE from arachidonate: 12-HETE/12-HpETE, 12-oxo-ETE, and 12-oxo-ETrE. Second, we found no evidence for formation of 15-hydroxyeicosatrienoic acid isomers, unlike rat epidermal microsomes, which generate 15-hydroxy-5,8,11-eicosatrienoic acid from arachidonate (Van Wauwe et al., 1991 , 1992 . This might represent a species difference or the levels of this regioisomer were just too low to be detected in our assay system. In human skin, HETrE formation has been reported from dietary polyunsaturated fatty acid, but not from arachidonic acid. For example, human epidermal cells can generate 15-hydroxy-8,11,13-eicosatrienoic acid from γ-linolenic acid (Ziboh et al., 2000) .
Even though EET biosynthesis was not detected in vitro, CYP2B19 is expressed in mouse epidermal keratinocytes; CYP2B19-derived peptides were identified This article has not been copyedited and formatted. The final version may differ from this version. unequivocally by mass spectrometry, following immunoaffinity chromatography (Du et al., 2005) . In addition to explanations already discussed why EET biosynthesis was not detected, we question whether epidermal epoxygenases utilize exogenous arachidonic acid efficiently in the microsomal environment. Cyclooxygenase (PTGS1 and PTGS2) activity levels differed depending on whether substrate was exogenous or endogenous arachidonic acid (Chulada et al., 1996) . In our system, exogenous arachidonate was utilized much more efficiently by epidermal lipoxygenases and cyclooxygenases, than epoxygenases. Even though soluble and microsomal epoxide hydrolases are expressed in the epidermis , we found little evidence for hydrolysis of EETs to vicinal diols using an inhibitor of soluble epoxide hydrolase--the form mainly responsible for hydrolysis of epoxy fatty acids (Newman et al., 2005) .
The NADPH-dependent products I and II (12-oxo-ETrE and 12-HETrE, respectively) appeared to form at the expense of product III (12-oxo-ETE). This was the first evidence for a precursor-product relationship. The time dependent accumulation and disappearance of epidermal [ 14 C]-products (I-IV) lend credibility to the idea that HETrE biosynthesis in mouse epidermal microsomes shares some of the same intermediates as reported for bovine corneal and rat epidermal microsomes (Van Wauwe et al., 1992; Yamamoto et al., 1994) . In the mouse epidermal microsome system, we identified 12-HETE and 12-HETrE as end products, and 12-oxo-ETE and 12-oxo-ETrE as intermediates in the formation of 12-HETrE.
Mechanistically, 12-HETrE synthesis could involve lipoxygenases and/or cytochromes P450 (Nishimura et al., 1991; Van Wauwe, 1991 , 1992 Yamamoto et al., 1994) . CYP4B1 has been implicated in 12-HETrE formation in the cornea (Mastyugin et This article has not been copyedited and formatted. The final version may differ from this version. , 1987; Yoshimoto and Takahashi, 2002; Antón and Vila, 2000; Funk et al., 2002) . That 12-HETE was the most abundant end product is consistent with previous studies establishing 12-lipoxygenase as the major lipoxygenase activity in mouse skin microsomes (Nakadate et al., 1986) .
Enzymes responsible for the NADPH-dependent conversion of 12-oxo-ETE to 12-oxo-ETrE and 12-HETrE have not been studied in the epidermis. However, in porcine leukocytes a microsomal NAD + -dependent dehydrogenase activity was characterized that generates 12-oxo-ETE from 12-HETE. This oxidation step was prerequisite for maximal activity of a cytosolic NADH-dependent 10,11-reductase (Wainwright et al., 1990; Wainwright and Powell, 1991) . Involvement of a cytosolic reductase in mouse epidermis is contradicted by the observation that microsomes prepared from epidermis and full-thickness skin (epidermis and dermis) were competent to generate12-HETrE; however, we cannot rule out minor cytosolic contamination. The 12-/15-oxo-ETE, and 12-/15-oxo-ETrE intermediates are common to diverse cell systems, suggesting that pathways for HETrE are conserved in mammalian skin, cornea, leukocytes, and quite possibly many other tissues. Important differences might In differentiating keratinocytes, CYP-derived EETs are implicated in mechanisms regulating transglutaminase enzyme activities, which are critical for normal epidermal cornification (Ladd et al., 2003) . Is epidermal HETrE biosynthesis physiological relevant? In the cornea, 12R-HETrE formation is enhanced by injury and hypoxia, and its proinflammatory properties include vasodilation of blood vessels, neutrophil chemoattraction, endothelial cell proliferation and neovascularization (Murphy et al., 1988; Stoltz and Schwartzman, 1997) . Both 12-HETE enantiomers are substrate for 12-HETrE biosynthesis, but only 12R-HETrE has significant proinflammatory properties Stoltz and Schwartzman, 1997) . In guinea pig skin, 12R-HETrE is also proinflammatory, enhancing delayed-type hypersensitivity inflammatory reactions at dosages as low as 1 fmol (Conners et al., 1995) . Neither of the 12-HETE enantiomers or 12S-HETrE had this activity.
The extent that epidermally-derived 12-HETE serves as precursor for 12-HETrE biosynthesis in human skin is unknown since this pathway has not been studied in human epidermal cells, nor have cellular 12-HETrE levels been reported for normal or diseased skin. In hyperproliferative dermatoses (e.g., psoriatic), 12-HETE accumulates to greater levels in lesional (vs. normal) skin (Hammarström et al., 1979) . The 12R-HETE enantiomer predominates and is more chemotactic (Woollard, 1986; reviewed by: Ikai, 1999; Fogh and Kragballe, 2000) . Opposing pro-and anti-inflammatory activities for 12-and 15-HETrE make sense biologically, to regulate cutaneous inflammatory and immune responses. In this regard, it was proposed that 15-HETE might influence the development of psoriatic lesions by its ability to inhibit synthesis of the proinflammatory lipids 5-and 12-HETE (reviewed by Ikai, 1999 
